WELLINGTON MANAGEMENT GROUP LLP - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 201 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.

Quarter-by-quarter ownership
WELLINGTON MANAGEMENT GROUP LLP ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$5,948,924
+30.1%
155,731
+22.8%
0.00%0.0%
Q2 2023$4,572,702
-72.9%
126,773
-57.3%
0.00%
-66.7%
Q4 2022$16,899,129
+19.9%
296,997
-16.6%
0.00%0.0%
Q3 2022$14,089,000
+70.2%
356,319
+89.4%
0.00%
+50.0%
Q2 2022$8,277,000
+2552.9%
188,124
+968.1%
0.00%
Q4 2019$312,000
+30.0%
17,613
+25.9%
0.00%
Q2 2019$240,000
+5.7%
13,988
-0.7%
0.00%
Q1 2019$227,000
-39.0%
14,083
-31.3%
0.00%
Q3 2018$372,000
-89.6%
20,502
-90.4%
0.00%
-100.0%
Q2 2018$3,589,000
+5.4%
212,738
+22.4%
0.00%0.0%
Q1 2018$3,405,000
+42.0%
173,836
+46.9%
0.00%0.0%
Q4 2017$2,398,000
-48.4%
118,376
-55.9%
0.00%0.0%
Q4 2015$4,648,000
+239.0%
268,195
+162.7%
0.00%
Q3 2015$1,371,000
+26.9%
102,083
+20.1%
0.00%
Q1 2014$1,080,00085,0000.00%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q4 2017
NameSharesValueWeighting ↓
Third Security, LLC 1,129,551$51,293,0007.24%
First Light Asset Management, LLC 2,050,273$93,103,0005.59%
TRAN CAPITAL MANAGEMENT, L.P. 1,350,870$61,343,0005.06%
SNYDER CAPITAL MANAGEMENT L P 3,176,404$144,241,0004.04%
DOHENY ASSET MANAGEMENT /CA 91,930$4,175,0002.69%
Redwood Investments, LLC 538,656$24,460,0001.97%
HighMark Wealth Management LLC 53,457$2,427,0001.78%
Taylor Wealth Management Partners 85,409$3,878,0001.37%
SILVERARC CAPITAL MANAGEMENT, LLC 66,673$3,028,0001.35%
Granite Investment Partners, LLC 919,029$41,733,0001.29%
View complete list of HALOZYME THERAPEUTICS INC shareholders